Clinical Trial Update: Cardiovascular Disease in HIV and Hepatitis C: Risk Outcomes After Hepatitis C Eradication [Phase 4]

View source ↗

Summary

Phase 4 trial updating cardiovascular risk outcomes after hepatitis C eradication in individuals with HIV and hepatitis C; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• HIV Infection
• Hepatitis C

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Cardiovascular Diseases, Hepatitis C | Phase 4 | Status: COMPLETED | Results posted: 2023-05-22